相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD)
Julie Martin-Grace et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting
Victoria Chatzimavridou-Grigoriadou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Equivalent Efficacy and Decreased Rate of Overcorrection in Patients with Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Oose Tolvaptan
Ramy M. Hanna et al.
KIDNEY MEDICINE (2020)
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department
Luigi Mario Castello et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
Rossana Berardi et al.
ONCOTARGET (2017)
Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines
Ewout J. Hoorn et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness
Yu-hong Liu et al.
MEDICINE (2017)
Long-Term Vaptan Treatment of Idiopathic SIADH in an Octogenarian
Stefan Buettner et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion
Ploutarchos Tzoulis et al.
CLINICAL ENDOCRINOLOGY (2016)
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
Ramon De las Penas et al.
SUPPORTIVE CARE IN CANCER (2016)
Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: A large population study
Christian Selmer et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH)
Birgit Harbeck et al.
ENDOCRINE (2016)
The diagnosis and management of inpatient hyponatraemia and SIADH
Paul Grant et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Clinical practice guideline on diagnosis and treatment of hyponatraemia
Goce Spasovski et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations
Joseph G. Verbalis et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Hyponatremia in Hospitalized Cancer Patients and Its Impact on Clinical Outcomes
Simit M. Doshi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Clinical management of SIADH
Peter Gross
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2012)
Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)
Masunori Matsuzaki et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion
Joseph G. Verbalis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
Tomas Berl et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The occurrence of hyponatremia in SCLC and the influence on prognosis A retrospective study of 453 patients treated in a single institution in a 10-year period
Olfred Hansen et al.
LUNG CANCER (2010)
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation
Marta Bondanelli et al.
JOURNAL OF NEUROTRAUMA (2007)
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
Robert W. Schrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure -: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
L Klein et al.
CIRCULATION (2005)
Evaluation and management of hypo-osmolality in hospitalized patients
N Janicic et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2003)
分享论文
